Literature DB >> 16450345

Structural variants in the vesicular monoamine transporter do not contribute to sporadic Parkinson's disease.

Charles Glatt, Maricel Almonte, Travis Taylor, Robert H Edwards, Nelson Freimer, Caroline Tanner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16450345     DOI： 10.1002/mds.20798

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  N-terminus regulation of VMAT2 mediates methamphetamine-stimulated efflux.

Authors:  B Torres; A E Ruoho
Journal:  Neuroscience       Date:  2013-12-07       Impact factor: 3.590

2.  Vmat2 heterozygous mutant mice display a depressive-like phenotype.

Authors:  Masato Fukui; Ramona M Rodriguiz; Jiechun Zhou; Sara X Jiang; Lindsey E Phillips; Marc G Caron; William C Wetsel
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

Review 3.  Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.

Authors:  Ciara A Martin; David E Krantz
Journal:  Neurochem Int       Date:  2014-04-03       Impact factor: 3.921

4.  Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson's disease.

Authors:  Meghan L Bucher; Caitlyn W Barrett; Connor J Moon; Amanda D Mortimer; Edward A Burton; J Timothy Greenamyre; Teresa G Hastings
Journal:  NPJ Parkinsons Dis       Date:  2020-11-13

5.  Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.

Authors:  W Michael Caudle; Jason R Richardson; Min Z Wang; Tonya N Taylor; Thomas S Guillot; Alison L McCormack; Rebecca E Colebrooke; Donato A Di Monte; Piers C Emson; Gary W Miller
Journal:  J Neurosci       Date:  2007-07-25       Impact factor: 6.167
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.